Wednesday, November 18, 2015
Print Current Day:
|
|
SESSION 23 SCHEDULE | |
Wednesday
SESSION 23:
LOWER EXTREMITY OCCLUSIVE DISEASE MANAGEMENT – HOT TOPICS AND NEW DEVELOPMENTS
Moderators:Enrico Ascher, MD / Craig M. Walker, MD
|
|
x | |
6:40 AM - 6:45 AM | Prosthetic (PTFE) Grafts Are As Good Or Better Than Non-Greater Saphenous Autologous Vein Grafts For Below The Knee (BTK) Bypasses |
Presenter(s):Rabih A. Chaer, MD | |
View Slides in PDF | |
6:46 AM - 6:51 AM | 12 Commandments To Make BTK Interventions For CLI Succeed |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
View Slides in PDF | |
6:52 AM - 6:57 AM | What Is The Best Way To Deal Endovascularly With SFA Occlusions To Its Origin |
Presenter(s):George H. Meier III, MD | |
View Slides in PDF | |
6:58 AM - 7:03 AM | 12-Month Results With The Endovascular Tacking Device (Tack-It) For Treating Flow Limiting Post PTA Dissections: The TOBA Trial |
Presenter(s):David H. Deaton, MD, FACS | |
View Slides in PDF | |
7:04 AM - 7:09 AM | New Approaches To Limb Salvage In CLI Due To Very Distal Disease: Pedal Loop, Transcollateral And Small Artery Access In The Foot: Techniques, Tips And Tricks |
Presenter(s):Roberto Ferraresi, MD | |
View Slides in PDF | |
7:10 AM - 7:15 AM | Fast, Cheap Way To Cross Tibial CTOs Antegrade And When It Doesn’t Work, Improved Pedal Access Is Available: Techniques And Equipment |
Presenter(s):Gary M. Ansel, MD | |
View Slides in PDF | |
7:16 AM - 7:21 AM | Technical Tips, Pitfalls And Midterm Results With Pedal Access Procedures |
Presenter(s):Hosam F. El Sayed, MD | |
View Slides in PDF | |
7:22 AM - 7:27 AM | How Does Stent Design Influence Results Of SFA Stenting: Advantages And Limitations Of Newer Stents: Supera, Tigris, Biomimics, Etc. |
Presenter(s):Marc Bosiers, MD / Koen Deloose, MD | |
View Slides in PDF | |
7:28 AM - 7:33 AM | DEBATE: Based On 5-Year Results, The Zilver PTX Stent Is The Treatment Of Choice For SFA Occlusive Disease |
Presenter(s):Michael D. Dake, MD | |
View Slides in PDF | |
7:34 AM - 7:39 AM | <>DEBATE: Zilver PTX Stents Are Effective For Long Or Calcified SFA Lesions: But All Other SFA Lesions Should Be Treated With Drug Eluting Balloons (DEBs) |
Presenter(s):Thomas Zeller, MD | |
View Slides in PDF | |
7:40 AM - 7:46 AM | Panel Discussion |
END OF SESSION 23 | |
SESSION 24 SCHEDULE | |
Wednesday
SESSION 24:
MORE LOWER EXTREMITY HOT TOPICS AND NEW DEVELOPMENTS
Moderators:Giancarlo Biamino, MD, PhD / Kenneth Ouriel, MD, MBA
|
|
x | |
7:46 AM - 7:51 AM | Comparison Of Tibial Bypasses With Saphenous Vein vs. Heparin Bonded PTFE (Propaten): Current Indications For Prosthetic Tibial Bypasses And New Developments For Limb Salvage |
Presenter(s):Richard F. Neville, MD | |
View Slides in PDF | |
7:52 AM - 7:57 AM | In Patients With Extensive Gangrene From CLI (Rutherford 5 And 6), Limited Vein And Occlusive Disease Of The SFA And Distal Arteries, Endovascular Treatment Of The SFA And A Short Vein Distal Bypass Is The Best Way To Achieve Limb And Patient Survival |
Presenter(s):Francesco Spinelli, MD | |
View Slides in PDF | |
7:58 AM - 8:03 AM | Below The Ankle And Perimalleolar Occlusive Disease With CLI: Tips And Tricks For Treating It Endovascularly And When They Should Be Used: Hydrodynamic Boost To Re-Enter The Tibial Artery True Lumen And Venous Arterialization |
Presenter(s):Roberto Ferraresi, MD | |
View Slides in PDF | |
8:04 AM - 8:09 AM | New Tips, Tricks And Devices For Pedal And Other Distal Access Procedures |
Presenter(s):Andrej Schmidt, MD | |
View Slides in PDF | |
DRUG ELUTING BALLOONS (DEBS) | |
8:10 AM - 8:15 AM | Importance Of Trial Design And Other Factors In Evaluating The Differing Results With DEBs |
Presenter(s):Kenneth Rosenfield, MD | |
View Slides in PDF | |
8:16 AM - 8:21 AM | Under What Conditions Should DEBs Be Used Preferentially: Diabetics, Calcified Lesions, Extensive Foot Necrosis: What Does It Take To Make DEBs Work Optimally |
Presenter(s):Francesco Liistro, MD | |
View Slides in PDF | |
8:22 AM - 8:27 AM | 2-Year Results With The Lutonix (Bard) DEB vs. Uncoated Balloon Angioplasty (POBA): The LEVANT II Trial In The SFA And BTK Lesions |
Presenter(s):Andrej Schmidt, MD / Dierk Scheinert, MD / Kenneth Rosenfield, MD / Marianne Brodmann, MD / Thomas Zeller, MD | |
View Slides in PDF | |
8:28 AM - 8:33 AM | In Femoropopliteal Stenting Does Drug Elution Make A Difference vs. Uncoated Stents: New Data From The MAJESTIC Trial |
Presenter(s):Stefan Mueller-Huelsbeck, MD | |
View Slides in PDF | |
8:34 AM - 8:39 AM | Access For BTK Interventions Via Puncture Through Totally Occluded SFAs (With Or Without A Previous Stent): How To Do It |
Presenter(s):Luigi Inglese, MD | |
8:40 AM - 8:45 AM | What The Surgeon Should NOT Do To Preserve Options For Future Endovascular Therapy And Vice Versa |
Presenter(s):Sigrid Nikol, MD | |
View Slides in PDF | |
8:46 AM - 8:52 AM | Panel Discussion |
END OF SESSION 24 | |
SESSION 25 SCHEDULE | |
Wednesday
SESSION 25:
MORE LOWER EXTREMITY NEW DEVELOPMENTS AND HOT TOPICS
Moderators:Giancarlo Biamino, MD, PhD / Frank J. Veith, MD
|
|
x | |
8:52 AM - 8:57 AM | DEBATE: What Percent Of CLI Patients Will Require An Open Surgical Procedure At Some Point In Their Course: An Interventionist's Point Of View |
Presenter(s):Giancarlo Biamino, MD, PhD | |
View Slides in PDF | |
8:58 AM - 9:03 AM | DEBATE: What Percent Of CLI Patients Will Require An Open Procedure At Some Point In Their Course: An Endovascularly Oriented Vascular Surgeon's Point Of View |
Presenter(s):Joseph L. Mills, MD | |
View Slides in PDF | |
9:04 AM - 9:09 AM | 2-Year Positive Results With The In.Pact Admiral DEB To Treat SFA And Popliteal Lesions: The In.Pact SFA RCT Shows Better Patency And Decreased Reintervention Rates Compared To POBA |
Presenter(s):Peter A. Schneider, MD / Gunnar Tepe, MD / John R. Laird, MD | |
View Slides in PDF | |
9:10 AM - 9:15 AM | Value Of The In.Pact DEB To Treat Long TASC C And D Lesions: From The In.Pact SFA Trial Long Lesion Cohort |
Presenter(s):Gunnar Tepe, MD | |
View Slides in PDF | |
9:16 AM - 9:21 AM | Critical Analysis Of The LEVANT II And In.Pact SFA RCTs Of DEBs vs. POBA: What Are The Take Home Messages |
Presenter(s):Thomas Zeller, MD | |
View Slides in PDF | |
9:22 AM - 9:27 AM | Update On The Status Of Drug Eluting Balloons In The US Currently – And What Is Coming |
Presenter(s):Edward Y. Woo, MD | |
View Slides in PDF | |
TREATMENT OF LEG AND FOOT ARTERY OCCLUSIVE DISEASE | |
9:28 AM - 9:33 AM | Foot Artery Disease In CLI: Innocent Bystander Or Leading Villain: When Should It Be Treated; When Should It Not Be Treated; And When Can It Not Be Treated: Some Patent Arteries In Leg And Foot Are Not Seen On DSA: How They Can Be Visualized |
Presenter(s):Roberto Ferraresi, MD | |
View Slides in PDF | |
9:34 AM - 9:39 AM | Future Of Pedal Access And Interventions: What Are Its Limits And Potential: Can It Be Achieved With Duplex Guidance And Can It Be Used For Atherectomy (With The Diamond Back Device): Technical Tips |
Presenter(s):Jihad A. Mustapha, MD | |
View Slides in PDF | |
9:40 AM - 9:45 AM | DEBs And Drug Eluting Stents (DESs) For BTK Arteries: Where Are We And What Is The Future |
Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR | |
View Slides in PDF | |
9:46 AM - 9:51 AM | Novel Hybrid Technique For Treating Complex Disease Involving CFA, SFA And Tibial Disease: Distal Access, Retrograde Wire Passage To A Common Femoral Arteriotomy Facilitates Complex Prograde Endovascular Treatments |
Presenter(s):Joshua D. Adams, MD / Claudio J. Schonholz, MD | |
View Slides in PDF | |
9:52 AM - 9:59 AM | Panel Discussion |
9:59 AM - 10:12 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 25 | |
SESSION 26 SCHEDULE | |
Wednesday
SESSION 26:
MORE LOWER EXTREMITY NEW DEVELOPMENTS AND HOT TOPICS
Moderators:Daniel G. Clair, MD / Michael B. Silva, Jr., MD
|
|
x | |
10:12 AM - 10:17 AM | DEBATE: An Endovascular First Approach To All CLI Patients Results In Better Limb Salvage: Based On Long-Term Follow-Up Of A Single Vascular Surgical Center |
Presenter(s):Ramon L. Varcoe, MD | |
View Slides in PDF | |
10:18 AM - 10:23 AM | DEBATE: Not So: Some CLI Patients Are Still Best Treated First By An Open Bypass: Which Ones And An Endovascular First Policy Can Harm Such Patients |
Presenter(s):Michael S. Conte, MD | |
View Slides in PDF | |
10:24 AM - 10:29 AM | Consequences Of An “Endovascular First Policy For All CLI Patients”: They Are Real – Especially With TASC C And D Lesions |
Presenter(s):Ross Milner, MD | |
View Slides in PDF | |
10:30 AM - 10:35 AM | Consequences Of Failed Tibial Angioplasty: How Often Is The Distal Target Vessel Altered Or Symptoms Increased: Open Bypass As The Initial Treatment Is Better For CLI Patients With TASC D Lesions |
Presenter(s):Marc L. Schermerhorn, MD | |
View Slides in PDF | |
10:36 AM - 10:41 AM | Endovascular Treatments For TASC C And D Lesions Have Improved And Justifies Their Use With Such Lesions: Do Results Support This Use |
Presenter(s):Gary M. Ansel, MD | |
View Slides in PDF | |
10:42 AM - 10:47 AM | 5-Year Results With The Supera Interwoven Stent Are Better Than Other Bare Metal Stents (BMSs) And DEBs In A Propensity Matched Comparison |
Presenter(s):Andrej Schmidt, MD / Dierk Scheinert, MD / Sabine Steiner, MD | |
View Slides in PDF | |
10:48 AM - 10:53 AM | 3-Year Results From The US IDE Trial With The Supera Stent: How Does The Deployment Technique Influence Midterm Patency |
Presenter(s):Lawrence A. Garcia, MD | |
View Slides in PDF | |
10:54 AM - 10:59 AM | Real World Experience With The Supera Stent For Long Challenging SFA/Pop Lesions: Deployment Tips And Mode Of Failure |
Presenter(s):D. Christopher Metzger, MD | |
View Slides in PDF | |
11:00 AM - 11:05 AM | 1-2-Year Good Results With The Xience Prime Balloon Expandable Everolimus DES For Long BTK Lesions Are Good: From The DESTINY 2 Trial |
Presenter(s):Marc Bosiers, MD / Patrick Peeters, MD | |
View Slides in PDF | |
11:06 AM - 11:12 AM | Panel Discussion |
NEW DEVELOPMENTS IN DEBS | |
Moderator(s): Peter A. Schneider, MD / Darren B. Schneider, MD | |
11:12 AM - 11:17 AM | Role Of DEBs For Infrainguinal Lesions (SFA/Pop/BTK) In 2015 And The Future: What Is It And What Will It Be In Primary And Recurrent Lesions And ISR |
Presenter(s):Giancarlo Biamino, MD, PhD | |
View Slides in PDF | |
11:18 AM - 11:23 AM | DEBATE: Why We Should Stay Away From DEBs For BTK Interventions |
Presenter(s):Erich Minar, MD | |
View Slides in PDF | |
11:24 AM - 11:29 AM | DEBATE: DEBs For BTK Lesions Have A Bright Future: Why The In.Pact Deep Trial Did Not Work And Lessons Learned That Should Make DEBs Effective BTK Including In Crural Arteries |
Presenter(s):Francesco Liistro, MD | |
View Slides in PDF | |
11:30 AM - 11:35 AM | Ongoing Trials Of Drug Delivery Techniques And Improved Stents For BTK Arteries: The Future Is Bright |
Presenter(s):Andrej Schmidt, MD / Dierk Scheinert, MD | |
View Slides in PDF | |
11:36 AM - 11:41 AM | Late Patency And Limb Salvage Results After Plantar And Pedal Loop PTAs For CLI: How Do They Differ In Patients With Gangrene And Ulceration And Those With Rest Pain |
Presenter(s):Roberto Ferraresi, MD | |
View Slides in PDF | |
11:42 AM - 11:47 AM | Infrainguinal Artery Calcification In Fem/Pop And Tibial Arteries: What Is Its Location And Nature And How Does It Impact On Endovascular Treatments In The Thigh, Leg And Foot |
Presenter(s):Jihad A. Mustapha, MD | |
View Slides in PDF | |
11:48 AM - 11:53 AM | Meta-Analysis Of Results With Venous Arterialization For Limb Salvage: When Does It Work And Why: Properly Done It Offers A Hope For Limb Salvage In Otherwise Hopeless Circumstances |
Presenter(s):Pramook Mutirangura, FRCS (Edinburgh) | |
View Slides in PDF | |
11:54 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 26 | |
SESSION 27 SCHEDULE | |
Wednesday
SESSION 27:
LOWER EXTREMITY NEW DEVELOPMENTS RELATED TO TREATMENT OF IN STENT RESTENOSIS (ISR)
Moderators:Andrej Schmidt, MD / Marc Bosiers, MD
|
|
x | |
1:00 PM - 1:05 PM | How Can ISR Be Classified And What Is Currently The Best Treatment For Each Class |
Presenter(s):Peter A. Schneider, MD | |
View Slides in PDF | |
1:06 PM - 1:11 PM | The Spectranetics Excimer Laser Plus Balloon Angioplasty Is The Best Treatment For ISR: Based On The EXCITE-ISR Trial: Should The Balloon Be A DEB |
Presenter(s):Craig M. Walker, MD / D. Christopher Metzger, MD | |
View Slides in PDF | |
1:12 PM - 1:17 PM | Atherectomy (Silverhawk) Plus DEB Is The Best Treatment For ISR And Is Cost Effective: Based On The DEFINITIVE AR Trial |
Presenter(s):Thomas Zeller, MD / Gunnar Tepe, MD | |
View Slides in PDF | |
1:18 PM - 1:23 PM | Viabahn Relining Is Usually The Best Treatment For ISR: Based On Updated 2-Year Results Of The RELINE Trial: When Is It Not The Best |
Presenter(s):Patrick Peeters, MD / Marc Bosiers, MD / Koen Deloose, MD | |
View Slides in PDF | |
1:24 PM - 1:29 PM | Viabahn Stent-Grafts Are Good Treatment For ISR: When Are They The Best: What Is The Pattern Of Failure And What Can Be Done To Prevent It |
Presenter(s):Johannes Lammer, MD | |
View Slides in PDF | |
1:30 PM - 1:35 PM | DEB With The Cotavance Balloon vs. POBA For ISR: Good 1-Year Results: The COPA CABANA Trial |
Presenter(s):Gunnar Tepe, MD | |
View Slides in PDF | |
1:36 PM - 1:41 PM | Panel Discussion |
END OF SESSION 27 | |
SESSION 28 SCHEDULE | |
Wednesday
SESSION 28:
NEW DEVELOPMENTS IN LOWER EXTREMITY STENT-GRAFTS, POPLITEAL ANEURYSMS AND OTHER CLI TOPICS OF INTEREST
Moderators:Wesley S. Moore, MD / Craig M. Walker, MD
|
|
x | |
1:42 PM - 1:47 PM | Emergency Treatment Of Vascular Injuries With Stent-Grafts (Covered Stents): Which Stent-Graft For Which Injuries And Other Tips And Tricks In Their Use |
Presenter(s):Maria Antonella Ruffino, MD | |
View Slides in PDF | |
1:48 PM - 1:53 PM | What Is The Best Current Treatment For Long SFA Occlusions: BMSs, DESs, DEBs, Atherectomy And PTA Or Viabahn Stent-Grafts |
Presenter(s):Johannes Lammer, MD | |
View Slides in PDF | |
1:54 PM - 1:59 PM | 3-Year Results With Heparin Bonded Viabahn Stent-Grafts To Treat Long SFA Occlusions |
Presenter(s):Michel M.P. Reijnen, MD, PhD | |
View Slides in PDF | |
2:00 PM - 2:05 PM | Heparin Bonding Probably Does Not Improve Results with PTFE Stent-Grafts Or Open PTFE Bypasses |
Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS | |
View Slides in PDF | |
POPLITEAL ANEURYSM HOT TOPICS (SEE ALSO SESSION 85) | |
2:06 PM - 2:11 PM | Endoluminal Bypasses With Stent-Grafts For Thrombosed Popliteal Aneurysms: When Can It Work And How To Do It |
Presenter(s):Giovanni Pratesi, MD | |
View Slides in PDF | |
2:12 PM - 2:17 PM | DEBATE: Most Popliteal Aneurysms Should Be Treated Endovascularly: What Are The Exceptions and What Is Their Proportion |
Presenter(s):Irwin V. Mohan, MBBS, MD, FRCS, FEBVS, FRACS | |
View Slides in PDF | |
2:18 PM - 2:23 PM | DEBATE: Not So: Endovascular Repair Of Popliteal Aneurysms May Not Be As Good As It’s Cracked Up To Be – Especially In Certain Circumstances: Open Repair Via A Posterior Approach Is Best For Most |
Presenter(s):Martin Bjorck, MD, PhD | |
View Slides in PDF | |
2:24 PM - 2:29 PM | Endovascular Stent-Graft Repair Is The Best Treatment For Most Popliteal Aneurysms: What Are The Exceptions |
Presenter(s):Franco Grego, MD | |
View Slides in PDF | |
2:30 PM - 2:35 PM | Open vs. Endo Repair For Popliteal Aneurysms: Which Is Best: From A Real World National Italian Registry |
Presenter(s):Walter Dorigo, MD | |
View Slides in PDF | |
2:36 PM - 2:41 PM | Surveillance Duplex Ultrasound Is Not Reliable For Predicting Stent-Graft Failure After Popliteal Aneurysm Repair But Is Reliable For Predicting Failure Of SFA Stent-Grafts For Occlusive Disease |
Presenter(s):Keith D. Calligaro, MD / Matthew J. Dougherty, MD | |
View Slides in PDF | |
OTHER LOWER EXTREMITY TOPICS OF INTEREST | |
Moderator(s): Joseph L. Mills, MD / Patrick J. Lamparello, MD | |
2:48 PM - 2:53 PM | Value Of Prostaglandins In CLI For Diabetics And Non-Diabetics: Beneficial Effects Can Be Documented By Flow Measurements |
Presenter(s):Afshin Assadian, MD | |
View Slides in PDF | |
2:54 PM - 2:59 PM | Myths Concerning Pedal Bypasses: Their Bad Reputation Is Undeserved: With Them And Pedal Loop Endovascular Techniques No Patient With CLI Should Be Untreatable |
Presenter(s):Hisham Rashid, FRCS, FRCS(Gen) | |
View Slides in PDF | |
3:00 PM - 3:05 PM | Failure Modes For Pedal Access Endovascular Interventions |
Presenter(s):Rabih A. Chaer, MD | |
View Slides in PDF | |
3:06 PM - 3:11 PM | Impact Of Nitinol Stent Oversizing On Outcomes Of Fempop Interventions: How Should Optimal Stent Size Be Determined |
Presenter(s):Nicolas A. Diehm, MD | |
View Slides in PDF | |
3:12 PM - 3:17 PM | Distal (Pedal) Bypasses vs. PTAs For The Treatment Of Tibial And Pedal Occlusive Lesions: Pros And Cons Of Each |
Presenter(s):Hany Zayed, MD | |
View Slides in PDF | |
3:18 PM - 3:23 PM | Panel Discussion |
3:23 PM - 3:33 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 28 | |
SESSION 29 SCHEDULE | |
Wednesday
SESSION 29:
ADVANCES IN THE TREATMENT OF ACUTE LIMB ISCHEMIA (ALI) AND INTERMITTENT CLAUDICATION (IC)
Moderators:Keith D. Calligaro, MD / Michael S. Conte, MD
|
|
x | |
ACUTE LIMB ISCHEMIA (SEE ALSO SESSION 62) | |
3:33 PM - 3:38 PM | DEBATE: All Patients With Acute Limb Ischemia (ALI) Should Be Treated Endovascularly: A Strategy For Doing So – Including Mechanical Thrombectomy: Which Device Is Currently Best |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
View Slides in PDF | |
3:39 PM - 3:44 PM | DEBATE: Some Patients With ALI Need Open Surgical Techniques: Who Are They And Why Are The Open Techniques Needed And Beneficial |
Presenter(s):Joseph L. Mills, MD | |
View Slides in PDF | |
3:45 PM - 3:50 PM | Update On Thrombosuction For ALI: What Are The Best Techniques: How To Do It And What Are The Results |
Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD | |
View Slides in PDF | |
3:51 PM - 3:56 PM | Intraoperative Venous Drainage Through A Hemodialysis System Can Be A Limb And Life Saving Technique For Patients With Late Stage ALI And Reperfusion Injury: How To Do It |
Presenter(s):Pramook Mutirangura, FRCS (Edinburgh) | |
View Slides in PDF | |
NEW DEVELOPMENTS IN THE MANAGEMENT OF INTERMITTENT CLAUDICATION (IC) AND OTHER CONDITIONS | |
3:57 PM - 4:02 PM | DEBATE: How Should Most Patients With IC Be Treated: An Interventional Cardiologist’s View |
Presenter(s):William A. Gray, MD | |
View Slides in PDF | |
4:03 PM - 4:08 PM | DEBATE: How Should Most Patients With IC Be Treated: A Vascular Surgeon’s View |
Presenter(s):Frank B. Pomposelli, MD | |
View Slides in PDF | |
4:09 PM - 4:14 PM | With Supervised Exercise For IC When Is Stenting Needed: Never? Rarely? |
Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR | |
View Slides in PDF | |
4:15 PM - 4:20 PM | Patients With IC Should Have A Trial Of Exercise Treatment And Be Informed About Risks And Benefits Before They Are Treated Interventionally |
Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS | |
View Slides in PDF | |
4:21 PM - 4:26 PM | Use Of Electronic Devices Like Fitbits To Improve IC Treatment |
Presenter(s):Robyn A. Macsata, MD | |
View Slides in PDF | |
4:27 PM - 4:32 PM | New Automated Device For Rapid Percutaneous Insertion Of Femoral Artery Sheath In Emergent Situations |
Presenter(s):Rajabrata Sarkar, MD, PhD | |
View Slides in PDF | |
4:33 PM - 4:39 PM | Panel Discussion |
END OF SESSION 29 | |
SESSION 30 SCHEDULE | |
Wednesday
SESSION 30:
CLI AND THE ANGIOSOME CONCEPT; REOPERATIONS AND REINTERVENTION; OTHER NEW CONCEPTS AND TECHNIQUES
Moderators:Timur P. Sarac, MD / Cynthia K. Shortell, MD
|
|
x | |
4:39 PM - 4:44 PM | DEBATE: The Angiosome Concept Has Been Proven Helpful With Open Surgical And Endovascular Treatments Of CLI With Gangrenous Or Ulcerated Lesions |
Presenter(s):Richard F. Neville, MD | |
View Slides in PDF | |
4:45 PM - 4:50 PM | DEBATE: The Angiosome Concept Has Not Been Proven Helpful In The Treatment Of CLI With Gangrenous Or Ulcerated Lesions |
Presenter(s):Bauer E. Sumpio, MD, PhD | |
View Slides in PDF | |
4:51 PM - 4:56 PM | Angiosome Targeted Revascularization Is More Important With Endovascular Repair Than Bypass Surgery |
Presenter(s):Maarit Venermo, MD, PhD | |
View Slides in PDF | |
4:57 PM - 5:02 PM | Critique Of The Angiosome Concept: It Is Not Simple: Outcomes Depend More On The Distribution System In The Foot Than Angiosomes |
Presenter(s):Roberto Ferraresi, MD | |
View Slides in PDF | |
5:03 PM - 5:08 PM | Is The Angiosome Concept Worthwhile And How Should It Be Used |
Presenter(s):Peter A. Schneider, MD | |
View Slides in PDF | |
5:09 PM - 5:14 PM | Update On The Angiosome Concept: It’s Not All It’s Cracked Up To Be: What Other Factors Are More Important |
Presenter(s):Hisham Rashid, FRCS, FRCS(Gen) | |
View Slides in PDF | |
5:15 PM - 5:20 PM | The Angiosome Concept Is Not Necessary To Achieve Limb Salvage With Ischemic Gangrenous Foot Lesions |
Presenter(s):Ignacio Escotto, MD | |
View Slides in PDF | |
5:21 PM - 5:26 PM | Angiosomes Of The Foot Have Tremendous Variability As Indicated By Laser-Assisted Indocyanine Green Imaging Using The SPY SYSTEM |
Presenter(s):Werner Lang, MD | |
View Slides in PDF | |
5:27 PM - 5:32 PM | The Importance Of Reoperation Or Reintervention When A Primary Procedure For CLI Fails And The Limb Is Rethreatened: 1, 2, 3, 4 And More Procedures Can Be Worthwhile: A Vascular Surgeon’s View |
Presenter(s):Evan C. Lipsitz, MD | |
View Slides in PDF | |
NEW CONCEPTS AND TECHNIQUES | |
5:33 PM - 5:38 PM | Vorapaxar - A New PAR-1 Receptor Blocker, Improves Cardiovascular And Limb Outcomes In PAD Patients: The FDA Agrees |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Slides in PDF | |
5:39 PM - 5:44 PM | When And How Should Distal Embolic Protection Devices Be Used With Lower Extremity Interventions |
Presenter(s):D. Christopher Metzger, MD | |
View Slides in PDF | |
5:45 PM - 5:55 PM | Panel Discussion End of Program D |
END OF SESSION 30 | |
SESSION 31 SCHEDULE | |
Wednesday
SESSION 31:
NATURAL HISTORY, MEDICAL TREATMENTS AND ANTI-ATHEROSCLEROTIC MEDICATIONS
Moderators:Keith D. Calligaro, MD / Hans-Henning Eckstein, MD, PhD
|
|
x | |
6:45 AM - 6:50 AM | Is Metabolic Syndrome A Marker Of Adverse Outcomes After Vascular Procedures: What Can Be Done To Improve The Situation |
Presenter(s):Alan Dardik, MD, PhD | |
View Slides in PDF | |
6:51 AM - 6:56 AM | Cilostazol (Pletal) Is An Underutilized Medication In Vascular Patients: It Can Promote Patency And Decrease Amputations After Arterial Revascularizations: What Is Optimal Timing And Dosing For Its Use |
Presenter(s):Todd R. Vogel, MD, MPH | |
View Slides in PDF | |
6:57 AM - 7:03 AM | How Should Beta Blockers Be Used In Vascular Patients Undergoing Procedures: Use And Overuse Can Harm Patients And Their Use Should Not Be A Quality Metric |
Presenter(s):Michael C. Stoner, MD | |
View Slides in PDF | |
7:04 AM - 7:09 AM | How Do Patient Risk Factors And Antiplatelet Medications Influence Myocardial Ischemia And Infarction In Patients Undergoing Open Arterial Operations: What Can Be Done To Decrease These Adverse Events |
Presenter(s):Caron B. Rockman, MD / Jeffrey S. Berger, MD, MS, FAHA, FACC | |
View Slides in PDF | |
7:10 AM - 7:15 AM | Smoking, Cholesterol, Obesity And BP: The Big 4 Modifiable Causes Of Vascular Disease: Fix Them And Live Forever: What Is Optimal Statin Usage |
Presenter(s):Richard Bulbulia, MA, MD, FRCS | |
View Slides in PDF | |
7:16 AM - 7:21 AM | What Is Happening With The AHA Cholesterol Guidelines: Should We Measure Serum Cholesterol: How Low Should The LDL Be Pushed To And Can It Get There |
Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC | |
View Slides in PDF | |
7:22 AM - 7:27 AM | Status Of Cholesterol Lowering Drug Zetia (Ezetimbe) And Its Combination With Statins (Vytorin): Do They Help To Prevent Cardiovascular Events More Than Statins Alone: Who Should Be On Them: The IMPROVE –IT Trial |
Presenter(s):Don Poldermans, MD | |
View Slides in PDF | |
7:28 AM - 7:33 AM | Status Of The New Cholesterol Lowering Drugs: The PCSK 9 Inhibitors (Evolucumab [Amgen] And Alirocumab [Sanofi]): Do They Decrease Cardiovascular Events: How Are They Given; What Are Their Downsides; What Will Their Role Be And When Will They Be Available |
Presenter(s):Ron Waksman, MD | |
View Slides in PDF | |
7:34 AM - 7:39 AM | Statins And Dual Antiplatelet Drugs Reduce Amputations: What Is The Evidence |
Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR | |
View Slides in PDF | |
7:40 AM - 7:48 AM | Panel Discussion |
END OF SESSION 31 | |
SESSION 32 SCHEDULE | |
Wednesday
SESSION 32:
RENAL DENERVATION AND OTHER TREATMENTS FOR RESISTANT HYPERTENSION: BLACK BOX WARNINGS; KEY CAROTID TOPIC
Moderators:Ronald L. Dalman, MD / Ali F. AbuRahma, MD
|
|
x | |
7:48 AM - 7:53 AM | Current Status Of Catheter Based Renal Radiofrequency Denervation For Hypertension: Where Is It Going |
Presenter(s):Horst Sievert, MD | |
View Slides in PDF | |
7:54 AM - 7:59 AM | Why The Renal Denervation RCTs Have Not Shown A Positive Effect: Does The Treatment Concept Have A Future |
Presenter(s):Michael R. Jaff, DO / Krishna J. Rocha-Singh, MD | |
View Slides in PDF | |
8:00 AM - 8:05 AM | What Is The Future For Renal Denervation: What Are Its Assets Beyond Lowering BP: Will It Become A Mainstream Treatment |
Presenter(s):Melvin D. Lobo, MBChB, PhD, FRCP | |
View Slides in PDF | |
8:06 AM - 8:11 AM | Does Surgical Renal Denervation Work: Why Does It Fail Long-Term: Is There A Bright Future For Renal Denervation |
Presenter(s):Juan C. Parodi, MD | |
View Slides in PDF | |
8:12 AM - 8:17 AM | Newer Methods To Achieve Renal Denervation: Can Catheter Based Ultrasound (Surround Sound) Be Effective And Safe For Lowering BP, For Treating Heart Failure (The RETREAT Trial): What About Catheter Chemical Denervation With Alcohol And DW 2013: How Are They Delivered |
Presenter(s):Horst Sievert, MD | |
View Slides in PDF | |
OTHER TREATMENTS FOR RESISTANT HYPERTENSION | |
8:18 AM - 8:23 AM | Update On Chronic Carotid Sinus Stimulation With An Implantable Device To Treat Resistant Hypertension |
Presenter(s):Fred A. Weaver, MD | |
View Slides in PDF | |
8:24 AM - 8:29 AM | Treatment Of Resistant Hypertension By The ROX AV Coupling Device: An Endovascular Technique To Create An Iliac A-V Fistula: Technique, Results And Risks |
Presenter(s):David H. Deaton, MD, FACS / Paul A. Sobotka, MD | |
View Slides in PDF | |
8:30 AM - 8:35 AM | Vascular Specialists Ignore Black Box Warnings About Certain Drugs And Their Optimal Usage Resulting In Poor Patient Care: What Can Be Done About It |
Presenter(s):Karthikeshwar Kasirajan, MD | |
View Slides in PDF | |
KEY CAROTID TOPIC | |
8:36 AM - 8:41 AM | What Is Best Medical Treatment (BMRx) For Patients With Carotid Disease |
Presenter(s):J. David Spence, MD | |
View Slides in PDF | |
8:42 AM - 8:49 AM | Panel Discussion |
END OF SESSION 32 | |
SESSION 33 SCHEDULE | |
Wednesday
SESSION 33:
TREATMENT AND PREVENTION OF COMPLICATIONS; ENDOTENSION AND ENDOLEAKS
Moderators:Neal S. Cayne, MD / Timur P. Sarac, MD
|
|
x | |
8:49 AM - 8:54 AM | Value Of Measuring Troponins Before And After Open Vascular Operations: When And How Does It Help In Patient Management |
Presenter(s):Caron B. Rockman, MD / Ramon Berguer, MD, PhD | |
View Slides in PDF | |
8:55 AM - 9:00 AM | Open And Endo Rescue Procedures When The Initial Procedure Goes Awry Or Has A Complication: Tips And Tricks For Getting Out Of Trouble |
Presenter(s):Michael B. Silva, Jr., MD | |
View Slides in PDF | |
9:01 AM - 9:06 AM | Is Endotension Still A Reality With Modern Vascular Imaging: What Conditions Can Mimic It |
Presenter(s):Jacques Busquet, MD | |
View Slides in PDF | |
9:07 AM - 9:12 AM | Strategies For Managing A Patient With A Growing AAA Sac After EVAR But No Apparent Endoleak: Open Or Laparoscopic, Fenestrated Cuff Or Relining Or Observe |
Presenter(s):Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS | |
View Slides in PDF | |
ENDOLEAKS | |
9:13 AM - 9:18 AM | Better Imaging Of Endoleaks (Type I) With Contrast MRI Permits Better Diagnosis And Treatment Leading To Better Outcomes |
Presenter(s):Frans L. Moll, MD, PhD | |
View Slides in PDF | |
9:19 AM - 9:24 AM | Aneurysm Sac Filling: A New Endovascular Technique To Eliminate Any Kind Of Endoleak |
Presenter(s):Michael J. Jacobs, MD | |
View Slides in PDF | |
9:25 AM - 9:30 AM | Partial Conversion To Treat Persistent Type 2 Endoleaks: When And How To Do It |
Presenter(s):Nicola Mangialardi, MD / Sonia Ronchey, MD, PhD | |
View Slides in PDF | |
9:31 AM - 9:36 AM | Diagnosis And Treatment Of Endoleaks With Nellix Endografts (EVAS): Much Is Different |
Presenter(s):Fabio Verzini, MD, PhD | |
View Slides in PDF | |
9:37 AM - 9:42 AM | Type 2 Endoleak Embolization By Laser-Assisted Transendograft Micropuncture: How To Do It And Results |
Presenter(s):Mark W. Mewissen, MD | |
View Slides in PDF | |
9:43 AM - 9:48 AM | Keys To Success With Embolic Treatment Of Complex Recalcitrant Type 2 Endoleaks After EVAR |
Presenter(s):Martin R. Back, MD | |
View Slides in PDF | |
9:49 AM - 9:54 AM | DEBATE: Fenestrated Cuffs Are The Best Way To Treat Persistent Type 1A Endoleaks After EVAR |
Presenter(s):Timothy A.M. Chuter, DM | |
View Slides in PDF | |
9:55 AM - 10:00 AM | DEBATE: Not So: Chimney Techniques Are The Best Way To Treat Persistent Type 1A Endoleaks After EVAR |
Presenter(s):Konstantinos P. Donas, MD | |
View Slides in PDF | |
10:01 AM - 10:08 AM | Panel Discussion |
10:08 AM - 10:20 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 33 | |
SESSION 34 SCHEDULE | |
Wednesday
SESSION 34:
HISTORY, MEDICAL/SURGICAL TOPICS AND IMPORTANT ISSUES
Moderators:Herbert Dardik, MD / Bruce A. Perler, MD, MBA
|
|
x | |
10:20 AM - 10:25 AM | What Did Leonardo da Vinci Know About Atherosclerosis Before William Harvey |
Presenter(s):Christopher K. Zarins, MD | |
View Slides in PDF | |
10:26 AM - 10:31 AM | The First Published Report On CAS In 1977: An Interesting Story: How Was It Received |
Presenter(s):Klaus D. Mathias, MD | |
View Slides in PDF | |
MEDICAL/SURGICAL TOPICS | |
10:32 AM - 10:37 AM | Tests For The Hypercoaguable State Are Overused And Unnecessary In Most Vascular Patients: When Are They Needed And Helpful |
Presenter(s):Elna M. Masuda, MD | |
View Slides in PDF | |
10:38 AM - 10:43 AM | Atherosclerotic Plaque Regression: Is It Now A Reality: How Can It Occur: And What Are The Expectations For The Future |
Presenter(s):Ralph G. DePalma, MD | |
View Slides in PDF | |
10:44 AM - 10:49 AM | Value Of Frailty Indices In Vascular Surgical Procedures: What Are They And How Can They Be Helpful |
Presenter(s):Gregory L. Moneta, MD | |
View Slides in PDF | |
10:50 AM - 10:55 AM | Tips And Tricks In The Management Of Pediatric Vascular Trauma |
Presenter(s):Meryl E. Davis, FRCS / George Hamilton, MD, FRCS | |
View Slides in PDF | |
10:56 AM - 11:01 AM | Panel Discussion |
IMPORTANT ISSUES | |
Moderator(s): Ramon Berguer, MD, PhD / Enrico Ascher, MD | |
11:01 AM - 11:06 AM | How Can Vascular Surgeons Reconcile Work And Family Responsibilities And Time Commitments And Succeed With Both |
Presenter(s):Marshall E. Benjamin, MD | |
View Slides in PDF | |
11:07 AM - 11:12 AM | Patient Benefit From Meetings Of The Vascular Community For Education, Innovation And Evidence With Active Collaboration Of CME And Industry Regulatory Bodies |
Presenter(s):Roger M. Greenhalgh, MD | |
View Slides in PDF | |
11:13 AM - 11:18 AM | Current Status Of MOC For Vascular Surgeons: Why Vascular Surgeons Should Join The Cardiologists To Resist The Existing Onerous Requirements |
Presenter(s):John F. Eidt, MD | |
View Slides in PDF | |
11:19 AM - 11:24 AM | Variability In Operating Time For The Same Procedure By Different Vascular Surgeons: How Does It Correlate With Outcomes: Do Slow Surgeons Get Better Or Worse Results |
Presenter(s):Jack L. Cronenwett, MD | |
View Slides in PDF | |
11:25 AM - 11:30 AM | How Should Academic Activity Be Rated And Rewarded: Should There Be Academic RVUs To Define And Quantitate Academic Activity And Productivity: How To Set Up Such A System |
Presenter(s):Mark G. Davies, MD / Alan B. Lumsden, MD, FACS | |
View Slides in PDF | |
11:31 AM - 11:36 AM | Lessons Learned From 2 Disasters: 9-11 And Superstorm Sandy |
Presenter(s):Mark A. Adelman, MD | |
View Slides in PDF | |
11:37 AM - 11:42 AM | Why Should Vascular Surgeons Get An MBA Or Other Advanced Degree |
Presenter(s):Robert B. McLafferty, MD | |
View Slides in PDF | |
11:43 AM - 11:48 AM | What Is The Value Of Vascular And Endovascular Societies: What Should They Do For Us And Our Specialty: Which Ones Should We Join And Why |
Presenter(s):Donald B. Reid, MD | |
View Slides in PDF | |
11:49 AM - 11:59 AM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor PromenadeVisit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 34 | |
SESSION 35 SCHEDULE | |
Wednesday
SESSION 35:
ISSUES, ETHICS, HEALTH CARE REFORM AND THE AFFORDABLE CARE ACT (ACA)
Moderators:Robert M. Zwolak, MD, PhD / Ronald L. Dalman, MD
|
|
x | |
1:00 PM - 1:05 PM | The Importance Of Dynasties In Vascular Surgery: Why They Develop And Why They Fall |
Presenter(s):Jerry Goldstone, MD, FACS, FRCSEd | |
View Slides in PDF | |
1:06 PM - 1:11 PM | An Ethicist Looks At Overuse Of Procedures And Admissions By Doctors And Hospitals: Why Our Health Care System Incentivizes Such Overuse In Every Institution |
Presenter(s):James W. Jones, MD, PhD, MHA | |
View Slides in PDF | |
1:12 PM - 1:17 PM | The Battle Of Quality vs. Quantity In Hospital Administration: Quantity Wins All Too Often |
Presenter(s):Clifford M. Sales, MD, MBA, FACS | |
View Slides in PDF | |
1:18 PM - 1:23 PM | How Patients (And Their Medical Doctors) Should Be Aware Of Unnecessary Tests And Procedures On Their Veins And Arteries: Such Procedural Overuse Can Harm Patients And Increase Health Care Costs |
Presenter(s):Russell H. Samson, MD, RVT, FACS | |
View Slides in PDF | |
1:24 PM - 1:29 PM | How To Survive In An ACO-ACA Environment: Is Our Health Care System Crumbling |
Presenter(s):Bruce A. Perler, MD, MBA | |
View Slides in PDF | |
1:30 PM - 1:35 PM | What Is Happening With The Device Tax Component Of The ACA: What Are The Detrimental Effects Of The ACA On Industry |
Presenter(s):Nicky James / Pete R. Yonkman / Kem Hawkins, MBA | |
View Slides in PDF | |
1:36 PM - 1:41 PM | The Negative Impact Of The ACA On The Country And Health Care Is Worse Than We Thought It Would Be |
Presenter(s):Clifford J. Buckley, MD | |
View Slides in PDF | |
1:42 PM - 1:47 PM | There Are Some Good Parts To The ACA That Should Be Preserved: How Can That Be Done |
Presenter(s):Timothy F. Kresowik, MD | |
View Slides in PDF | |
1:48 PM - 1:53 PM | Perils Of The ACA For Patients: Health Care Exchanges Or Short Changes |
Presenter(s):James H. Black, III, MD | |
View Slides in PDF | |
1:54 PM - 1:59 PM | Perspectives On Consolidation In The Health Care Industry: What Is Good And What Is Bad: How Can We Physicians Cope |
Presenter(s):Michael R. Jaff, DO | |
View Slides in PDF | |
2:00 PM - 2:05 PM | Medical Decision Making Should Be Shared With The Patient Especially With Vascular Patients: It Can Improve Care |
Presenter(s):Dirk T. Ubbink, MD, PhD | |
View Slides in PDF | |
2:06 PM - 2:11 PM | It Is An Imperfect World For Everyone – But Especially For Physicians And Super-Especially For Vascular Surgeons/Specialists |
Presenter(s):David H. Deaton, MD, FACS | |
View Slides in PDF | |
2:12 PM - 2:20 PM | Panel Discussion |
END OF SESSION 35 | |
SESSION 36 SCHEDULE | |
Wednesday
SESSION 36:
ACOs, GOVERNING BODIES (BOARDS/RRC), INDEPENDENCE, EDUCATION, REIMBURSEMENTS, TRAINING, SIMULATION
Moderators:Peter F. Lawrence, MD / Michel Makaroun, MD
|
|
x | |
2:20 PM - 2:25 PM | Strategies To Allow Us To Confront The Changing Health Care System And ACOs |
Presenter(s):John H. Furtek, BS, RT(r) | |
View Slides in PDF | |
2:26 PM - 2:31 PM | Why ACOs Have Not And Will Not Decrease Health Spending In Cardiovascular Care |
Presenter(s):Philip P. Goodney, MD, MS | |
View Slides in PDF | |
2:32 PM - 2:37 PM | Is The RRC-S (Residency Review Committee-Surgery) Working Well For Vascular Surgery: Should We Have An Independent RRC-VS |
Presenter(s):Ronald L. Dalman, MD | |
View Slides in PDF | |
2:38 PM - 2:43 PM | Current Impact Of The 0+5 Vascular Surgery Residency Programs: Should Vascular Surgery Now Become An Independent Specialty As It Is In Most Other Civilized Countries |
Presenter(s):John F. Eidt, MD | |
View Slides in PDF | |
2:44 PM - 2:49 PM | The Need For Continuing Evolution And Recognition Of Vascular Surgery As An Independent Specialty |
Presenter(s):James C. Stanley, MD | |
View Slides in PDF | |
2:50 PM - 2:55 PM | Role Of Our Vascular Journals In Dealing With Political, Training And Governance Issues Facing Vascular Surgery |
Presenter(s):Timothy M. Sullivan, MD | |
View Slides in PDF | |
2:56 PM - 3:01 PM | Update On 0+5 Vascular Residencies: Numbers, Levels Of Resident Satisfaction And Incidence Of Dropouts |
Presenter(s):Murray L. Shames, MD | |
View Slides in PDF | |
3:02 PM - 3:07 PM | Comparison Of Knowledge Base, Surgical Skills And Other Characteristics Of 5+2 And 0+5 Vascular Surgery Residents |
Presenter(s):Robyn A. Macsata, MD | |
View Slides in PDF | |
3:08 PM - 3:13 PM | Importance Of Promoting The Careers Of Junior Faculty Vascular Surgeons (As Well As Residents And Fellows): A System For Doing It |
Presenter(s):Karl A. Illig, MD / John F. Eidt, MD | |
View Slides in PDF | |
3:14 PM - 3:19 PM | Panel Discussion |
REIMBURSEMENT ISSUES | |
Moderator(s): Ramon Berguer, MD, PhD / Kim J. Hodgson, MD | |
3:19 PM - 3:24 PM | Update On Coding And Reimbursement Issues For Vascular Surgery: Now, In 2016 And Beyond |
Presenter(s):Sean P. Roddy, MD | |
View Slides in PDF | |
3:25 PM - 3:30 PM | Financial Impact Of The ACA To Date And In The Future: What Will It Mean To Vascular Surgeons |
Presenter(s):Robert M. Zwolak, MD, PhD | |
View Slides in PDF | |
SIMULATION ISSUES | |
3:31 PM - 3:36 PM | How To Shift The Learning Curve For Vascular Surgery From The Patient To A Model: The Vascular International Training Course Helps To Do This |
Presenter(s):Hans-Henning Eckstein, MD, PhD | |
View Slides in PDF | |
3:37 PM - 3:42 PM | Advantages In Patient Specific Simulation For EVAR For Elective And Ruptured AAAs |
Presenter(s):Isabelle van Herzeele, MD, PhD / Mario L. Lachat, MD | |
View Slides in PDF | |
3:43 PM - 3:48 PM | The Introduction Of New Technology For Treating Vascular Lesions May Lead To Unnecessary Adverse Events: Many Of These Can Be Avoided By Simulation And Team Training |
Presenter(s):Colin D. Bicknell, MD, FRCS | |
View Slides in PDF | |
3:49 PM - 4:00 PM | Panel Discussion And Break Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 36 | |
SESSION 37 SCHEDULE | |
Wednesday
SESSION 37:
VASCULAR CARE, MALPRACTICE LAW, CONTRACTS, COSTS, REIMBURSEMENT AND THE FDA
Moderators:Russell H. Samson, MD, RVT, FACS / Sean P. Roddy, MD
|
|
x | |
4:00 PM - 4:05 PM | The Indications And Results For EVAR Differ Widely In Different Regions: What Is The Reason |
Presenter(s):Barend M.E. Mees, MD, PhD | |
View Slides in PDF | |
4:06 PM - 4:11 PM | Health Care Literacy In Vascular Patients Is Inadequate: Do We Need Better Ways To Inform Patients |
Presenter(s):Olivier H.J. Koning, MD, PhD | |
View Slides in PDF | |
4:12 PM - 4:17 PM | What Is The Patient’s Compensation System Law: Where Is It In Effect; How Will It Help End The Malpractice Problem, Help Patients And Doctors To Be Treated Fairly And Cut Health Care Costs |
Presenter(s):O. William Brown, MD, JD | |
View Slides in PDF | |
4:18 PM - 4:23 PM | How Vascular Surgeons And Specialists Should Negotiate Contracts With Hospitals, Employers Or Partners: Tips And Tricks |
Presenter(s):Hillel Presser, Esq., MBA | |
View Slides in PDF | |
4:24 PM - 4:29 PM | Vascular Surgery Patients Readmissions: What Can And Cannot Be Modified And Why Financial Penalties For Many Of Them Are Unfair |
Presenter(s):Peter Henke, MD | |
View Slides in PDF | |
4:30 PM - 4:35 PM | How To Make EVAR More Cost Effective And Profitable For Hospitals In Today’s Health Care Environment |
Presenter(s):W. Charles Sternbergh III, MD | |
View Slides in PDF | |
4:36 PM - 4:41 PM | Tips And Tricks On How Vascular Surgeons Can Fairly Maximize Collections And Income In A Practice Or An Academic Setting |
Presenter(s):Alan M. Graham, MD | |
View Slides in PDF | |
4:42 PM - 4:47 PM | What The FDA Is Doing To Facilitate Access To New Devices Rapidly And With Assured Safety And Effectiveness – In Both The Civilian And Military Spheres |
Presenter(s):Kenneth J. Cavanaugh, Jr., PhD / J. Pablo Morales, MD / Brian Pullin, MD | |
View Slides in PDF | |
4:48 PM - 4:53 PM | When Do I Need A Physician Sponsored Investigative Device Exemption (PSIDE) And How Do I Get It |
Presenter(s):Dorothy B. Abel, BSBME | |
View Slides in PDF | |
4:54 PM - 4:59 PM | Tips And Tricks To Make A PSIDE Affordable |
Presenter(s):Carlos H. Timaran, MD | |
View Slides in PDF | |
5:00 PM - 5:06 PM | Panel Discussion |
END OF SESSION 37 | |
SESSION 38 SCHEDULE | |
Wednesday
SESSION 38:
ISSUES: PUBLISHING MDs’ RESULTS; RESEARCH TIPS; EVIDENCE BASED MEDICINE; RCTs; GUIDELINES; ACA; DISHONEST WITNESSES; VQIs AND SOCIETIES
Moderators:Anton N. Sidawy, MD, MPH / Ronald M. Fairman, MD
|
|
x | |
5:06 PM - 5:11 PM | Preferential Funding For Primary Care vs. Specialty Care And Penalties For Readmissions (As Promoted In The ACA) Are Bad For Patients And Society And Will Not Decrease Costs |
Presenter(s):Bruce A. Perler, MD, MBA | |
View Slides in PDF | |
5:12 PM - 5:17 PM | Publishing Vascular Surgeons’ Mortality Results In The Public Press Can Be A Disaster For The Surgeon And Bad For Patient Care: The UK Experience |
Presenter(s):Ian Loftus, MD | |
View Slides in PDF | |
5:18 PM - 5:23 PM | Issues In Planning And Interpreting Small Trials: How To Make Their Data Meaningful |
Presenter(s):Charles C. Miller, PhD | |
View Slides in PDF | |
5:24 PM - 5:29 PM | How To Get Access To Population Based Datasets |
Presenter(s):Todd R. Vogel, MD, MPH | |
View Slides in PDF | |
5:30 PM - 5:35 PM | The Tyranny Of p Values: The Importance Of Knowing The Details And Flaws In The Holy Grail Of RCTs |
Presenter(s):Jerry Goldstone, MD, FACS, FRCSEd | |
View Slides in PDF | |
5:36 PM - 5:41 PM | The New SVS Practice Guidelines For Lower Extremity Occlusive Disease: Key Take Home Messages And How They Prevent Over Usage Of SFA Stents |
Presenter(s):Frank B. Pomposelli, MD / Michael S. Conte, MD | |
View Slides in PDF | |
5:42 PM - 5:47 PM | Validity Of The New SVS Lower Extremity Threatened Limb Classification System: The WIFI System (Wound Ischemia And Foot Infection): It Allows Prediction Of Poor Outcomes With CLI Treatment |
Presenter(s):Marc L. Schermerhorn, MD / Joseph L. Mills, MD | |
View Slides in PDF | |
5:48 PM - 5:53 PM | What To Do When Physician Expert Witnesses Provide False Testimony Against You |
Presenter(s):O. William Brown, MD, JD | |
View Slides in PDF | |
5:54 PM - 5:59 PM | VQI In A Community Hospital: How It Succeeded In Improving Vascular Care And Resolving Harmful Turf Issues |
Presenter(s):Tej M. Singh, MD, MBA | |
View Slides in PDF | |
6:00 PM - 6:05 PM | DEBATE: Positive Value Of VQI Initiatives |
Presenter(s):Larry W. Kraiss, MD | |
View Slides in PDF | |
6:06 PM - 6:11 PM | DEBATE: Limitations And Possible Downsides Of VQI Initiatives |
Presenter(s):Kenneth Ouriel, MD, MBA | |
View Slides in PDF | |
6:12 PM - 6:17 PM | How Vascular Societies Should Prevent Risk Averse Behavior Of Surgeons And Gaming The System For The Benefit Of Surgeons And To The Detriment Of Patients: Do The Societies Do It Well |
Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS | |
View Slides in PDF | |
6:18 PM - 6:25 PM | Panel Discussion End of Program E |
END OF SESSION 38 | |
SESSION 39 SCHEDULE | |
Wednesday
SESSION 39:
MORE NEW DEVELOPMENTS RELATING TO THORACIC AORTA AND AORTIC DISSECTIONS
Moderators:Germano Melissano, MD / Michael J. Jacobs, MD
|
|
x | |
6:45 AM - 6:50 AM | How Often Are Additional Procedures (Open Or Endo) Required After An Open Ascending Aortic Repair Of A Type A Aortic Dissection (TAAD) |
Presenter(s):Ross Milner, MD | |
View Slides in PDF | |
6:57 AM - 7:02 AM | Open Retrograde Access To Branch Arteries As A Bailout For Failed Antegrade Access During F/BEVAR |
Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
View Slides in PDF | |
7:03 AM - 7:08 AM | Total Arch Replacement For Aortic Dissections: Value Of Frozen Elephant Trunk Procedures With EVITA, Jotec Or Thoraflex Hybrid (Vascutek) Grafts |
Presenter(s):Aamir S. Shah, MD / Ali Khoynezhad, MD, PhD | |
View Slides in PDF | |
7:15 AM - 7:20 AM | DEBATE: Branched Grafts Are The Best Endovascular Method To Treat Arch Aneurysms And TAAAs: Parallel Grafts Have Disadvantages |
Presenter(s):Stephan Haulon, MD | |
View Slides in PDF | |
7:21 AM - 7:26 AM | DEBATE: Disadvantages Of Off-The-Shelf And Patient Specific Branched Grafts: Parallel Grafts Are Better Solutions |
Presenter(s):Armando C. Lobato, MD, PhD | |
View Slides in PDF | |
7:27 AM - 7:32 AM | Pitfalls In F/BEVAR And How To Deal With Them |
Presenter(s):Götz M. Richter, MD, PhD | |
View Slides in PDF | |
7:33 AM - 7:38 AM | PET CT With 18F-FDG Can Predict Late Aortic Complications After TEVAR For TBADs |
Presenter(s):Natzi Sakalihasan, MD, PhD | |
View Slides in PDF | |
7:39 AM - 7:44 AM | Influence Of Respiratory And Cardiac Induced Movement On Precise Aortic Arch Endograft Deployment |
Presenter(s):Geert Willem H. Schurink, MD, PhD | |
View Slides in PDF | |
7:45 AM - 7:51 AM | Panel Discussion |
6:51 PM - 6:56 AM | Clinical Outcomes Of TBADs In Patients With Connective Tissue Diseases (Marfans, Loeys-Dietz, Etc.) Are Worse Than In Those Without |
Presenter(s):Richard G.J. Gibbs, FRCS | |
View Slides in PDF | |
7:09 PM - 7:14 PM | MR Elastography To Characterize The Aortic Wall: Implications For The Design And Sizing Of Ascending Aortic Devices |
Presenter(s):Rachel E. Clough, MD, PhD | |
View Slides in PDF | |
END OF SESSION 39 | |
SESSION 40 SCHEDULE | |
Wednesday
SESSION 40:
MORE TOPICS RELATING TO THE ASCENDING AORTA, THE ARCH AND PARALLEL GRAFTS
Moderators:Rodney A. White, MD / Mario L. Lachat, MD
|
|
x | |
7:52 AM - 7:57 AM | Further Experience With Longer Follow-Up On Arch Chimney Grafts: When Do They Work And Pitfalls To Avoid So They Do Not Fail |
Presenter(s):Nicola Mangialardi, MD / Sonia Ronchey, MD, PhD | |
View Slides in PDF | |
7:58 AM - 8:03 AM | In Vitro Analysis Of Parallel Grafts: How They Work And Why They Fail: New Lessons Learned |
Presenter(s):Jan D. Blankensteijn, MD | |
View Slides in PDF | |
8:04 AM - 8:09 AM | Tips And Tricks To Facilitate Successful Use Of Branched Endografts And Pitfalls To Avoid |
Presenter(s):Martin J. Austermann, MD | |
View Slides in PDF | |
8:10 AM - 8:15 AM | Use Of The VORTEC Technique – A Clampless, Sutureless Anastomosis Using An Endograft Connector To Revascularize The Supra-Aortic Branches Simplifies Hybrid Arch Repairs: Technique And Results |
Presenter(s):Zoran Rancic, MD, PhD / Mario L. Lachat, MD | |
View Slides in PDF | |
8:16 AM - 8:21 AM | Single Innominate Chimney Grafts: When Is It A Good Choice And When Is It Not |
Presenter(s):Boonprasit Kritpracha, MD | |
View Slides in PDF | |
8:22 AM - 8:27 AM | Various Cardiac Access Routes To Treat Ascending Aortic And Arch Lesions: Advantages And Limitations |
Presenter(s):Tilo Kölbel, MD, PhD | |
View Slides in PDF | |
8:28 AM - 8:33 AM | Redo Procedures After TEVAR: Why Needed; Tips, Tricks And Results; Value Of A Self-Expanding Extra Large Stent (Jotec E-XL) |
Presenter(s):Germano Melissano, MD / Roberto Chiesa, MD | |
View Slides in PDF | |
8:34 AM - 8:39 AM | Retrograde Aortic Dissection After TEVAR: Incidence, Risk Factors, Precautions And Treatment |
Presenter(s):Joseph S. Coselli, MD / Ourania Preventza, MD | |
View Slides in PDF | |
8:40 AM - 8:46 AM | Panel Discussion |
END OF SESSION 40 | |
SESSION 41 SCHEDULE | |
Wednesday
SESSION 41:
MORE TOPICS RELATED TO FENESTRATED, BRANCHED AND PARALLEL GRAFTS; JUXTARENAL AAAs AND TAAAs
Moderators:Eric L.G. Verhoeven, MD, PhD / Timothy A.M. Chuter, DM
|
|
x | |
8:46 AM - 8:51 AM | Optimal Choice Of Bridging Stent-Grafts For F/BEVAR: What Is Available And Which Is Best |
Presenter(s):Richard G. McWilliams, FRCR, EBIR | |
View Slides in PDF | |
8:52 AM - 8:57 AM | 3 Or 4 FEVAR vs. Standard FEVAR With 2 Fenestrations And A Scallop For The SMA: Advantages, Limitations And Differing Results |
Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD | |
View Slides in PDF | |
8:58 AM - 9:03 AM | How To Avoid Brachial Or Axillary Access With Complex AAA Repairs: Tips And Tricks |
Presenter(s):Joshua D. Adams, MD / Claudio J. Schonholz, MD | |
View Slides in PDF | |
9:04 AM - 9:09 AM | DEBATE: EVAR With Short (8-15 mm) Necks Are Best Treated With Standard EVAR Using Newer Endograft Devices |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
View Slides in PDF | |
9:10 AM - 9:15 AM | DEBATE: EVAR With Short (8-15 mm) Necks Are Best Treated By FEVAR |
Presenter(s):Matthew J. Eagleton, MD | |
View Slides in PDF | |
9:16 AM - 9:21 AM | Strategies And Techniques To Treat Short Proximal Neck AAAs |
Presenter(s):Giovanni Torsello, MD | |
View Slides in PDF | |
9:22 AM - 9:28 AM | Panel Discussion |
Moderator(s): Jason T. Lee, MD / Stephan Haulon, MD | |
9:28 AM - 9:33 AM | DEBATE: Endovascular Methods Are Now The Best Treatment For Most TAAAs |
Presenter(s):Timothy A.M. Chuter, DM | |
View Slides in PDF | |
9:34 AM - 9:39 AM | DEBATE: Not So: Open Repair Is Still The Best Treatment For Many (Possibly Most) TAAAs |
Presenter(s):Hazim J. Safi, MD | |
View Slides in PDF | |
9:40 AM - 9:45 AM | Eight Simple Markers That Can Suggest The Presence Of A Thoracic Aneurysm |
Presenter(s):John A. Elefteriades, MD | |
View Slides in PDF | |
9:46 AM - 9:51 AM | With complicated TBADs, Are The Hard Indications For Treatment (Rupture And Malperfusion) Associated With Higher Mortality And Morbidity Than The Soft Indications (Pain And Persistent Hypertension) |
Presenter(s):Matt M. Thompson, MD | |
View Slides in PDF | |
9:52 AM - 9:57 AM | Update On Tips And Tricks For Treating Arterial Complications Of Ehlers-Danlos Syndrome, Marfan’s And Other Connective tissue Disorders: Endografts Can Be Valuable |
Presenter(s):James H. Black, III, MD | |
View Slides in PDF | |
9:58 AM - 10:03 AM | Accurate Placement Of Thoracic Endografts Parallel To The Aortic Arch By Controlling Device Angulation Improves Outcomes: Techniques For Doing So |
Presenter(s):Ali Azizzadeh, MD | |
View Slides in PDF | |
10:04 AM - 10:09 AM | Purse-String Temporary Closure Of Femoral Access Sites During Complex EVARs (B/FEVAR) To Decrease Limb And Spinal Cord Ischemia |
Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD | |
View Slides in PDF | |
10:10 AM - 10:15 AM | How To Identify Healthy Aorta To Land The Ends Of Aortic Endografts With Complex AAAs: Is It Always Necessary To Do So |
Presenter(s):Matthew J. Eagleton, MD | |
View Slides in PDF | |
10:16 AM - 10:23 AM | Panel Discussion |
10:23 AM - 10:38 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 41 | |
SESSION 42 SCHEDULE | |
Wednesday
SESSION 42:
UPDATE ON THE STATUS OF MULTILAYER FLOW MODULATING (MLFM) STENTS FOR THE TREATMENT OF AORTIC ANEURYSMS AND DISSECTIONS
Moderators:Frank J. Veith, MD / Clifford J. Buckley, MD
|
|
x | |
10:38 AM - 10:43 AM | The MLFM Stent Is A Better Treatment For TAAAs Than F/BEVAR, Parallel Grafts, Hybrid Repairs And Full Open Repair And Here Is The Data |
Presenter(s):Sherif Sultan, MD, FRCS, EBQS-VASC | |
View Slides in PDF | |
10:44 AM - 10:49 AM | 4-Year Experience With MLFM Stents For The Treatment Of Complex Aortic Aneurysms: When They Do Not Work |
Presenter(s):Thomas Larzon, MD, PhD | |
View Slides in PDF | |
10:50 AM - 10:55 AM | 4-Year Results Of The MLFM Stent For The Treatment Of Complex Aortic Aneurysms: From The French Registry |
Presenter(s):Claude D. Vaislic, MD | |
View Slides in PDF | |
10:56 AM - 11:01 AM | Why I Am Still Somewhat Skeptical |
Presenter(s):Mark F. Fillinger, MD | |
View Slides in PDF | |
11:02 AM - 11:07 AM | For What Aortic Lesions Is The MLFM Stent An Effective Treatment: Tips And Tricks To Make It Work |
Presenter(s):Erno Remsey-Semmelweis, MD | |
View Slides in PDF | |
11:08 AM - 11:13 AM | When Is The MLFM Stent An Effective Treatment Of Arch And Ascending Aortic Aneurysms And When Is It Not: A Partly Positive View And Experience |
Presenter(s):Ralf R. Kolvenbach, MD | |
View Slides in PDF | |
11:14 AM - 11:19 AM | Treatment Of Aortic Dissection And Complex TAAAs With The MLFM Stent: Experience In More Than 30 Patients |
Presenter(s):Victor S. Costache, MD, PhD | |
View Slides in PDF | |
11:20 AM - 11:25 AM | Update On The MLFM Stent For Treatment Of Complex Aortic Aneurysms: Is Its Star Rising |
Presenter(s):Frans L. Moll, MD, PhD | |
View Slides in PDF | |
11:26 AM - 11:31 AM | Role Of Multilayer Uncovered Stents For The Successful Treatment Of TAAAs: The Concept Works: When And How |
Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD | |
View Slides in PDF | |
11:32 AM - 11:37 AM | Is The MLFM Stent A Valid Treatment In High Risk 80- And 90-Year Olds With Paravisceral And TAAAs |
Presenter(s):Arno von Ristow, MD | |
View Slides in PDF | |
11:38 AM - 11:43 AM | The MLFM Stent Has A Role In The Treatment Of Complex Aortic Aneurysms: What Is It And What More Do We Need To Know |
Presenter(s):Christos D. Liapis, MD | |
View Slides in PDF | |
11:44 AM - 11:49 AM | Histopathological Findings In Patients And Animals After Implantation Of MLFM Stents: Characteristics Of Endothelialization And Thrombus Formation |
Presenter(s):Antoine Alves, Dr. | |
View Slides in PDF | |
11:50 AM - 12:00 PM | Panel Discussion Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 42 | |
SESSION 43 SCHEDULE | |
Wednesday
SESSION 43:
MORE TOPICS RELATED TO AAAs, THE ABDOMINAL AORTA AND EVAR
Moderators:Roger M. Greenhalgh, MD / Kenneth Ouriel, MD, MBA
|
|
x | |
1:00 PM - 1:05 PM | Comparative Changes In Aortic Neck Morphology After EVAR And Open AAA Repair: Is Open Repair Really That Good: From The DREAM Trial |
Presenter(s):Jan D. Blankensteijn, MD | |
View Slides in PDF | |
1:06 PM - 1:11 PM | EVAR Strategy To Deal With A Proximal Neck Over 35 mm In Diameter |
Presenter(s):Jacques Busquet, MD | |
View Slides in PDF | |
1:12 PM - 1:17 PM | Patterns Of Rupture Of AAAs After EVAR: How Does It Differ From Rupture Patterns In Untreated AAAs |
Presenter(s):Markus K. Furrer, MD | |
View Slides in PDF | |
1:18 PM - 1:23 PM | Differences In AAA Size At Rupture Between Patients Treated By EVAR And Those Not So Treated |
Presenter(s):James May, MD, MS, FRACS, FACS | |
View Slides in PDF | |
1:24 PM - 1:29 PM | Progress In 18F-FDG Uptake On PET CT And Other Markers In Predicting AAA Rupture Risk |
Presenter(s):Natzi Sakalihasan, MD, PhD | |
View Slides in PDF | |
1:30 PM - 1:35 PM | Current Indications For Repairing Small AAAs (<5 cm) By EVAR; By Open Repair: Has Anything Changed |
Presenter(s):Ronald M. Fairman, MD | |
View Slides in PDF | |
1:36 PM - 1:42 PM | Panel Discussion |
END OF SESSION 43 | |
SESSION 44 SCHEDULE | |
Wednesday
SESSION 44:
RECORDED LIVE COMPLEX ENDOVASCULAR CASES: COMPLICATIONS WITH SOLUTIONS
|
|
x | |
1:42 PM - 1:54 PM | Single Session Pharmacomechanical Venous Thrombolysis |
Presenter(s):Gerard J. O'Sullivan, MD | |
View Slides in PDF | |
1:54 PM - 2:06 PM | Stent Graft-Induced New Entry (SINE) After TEVAR For Stanford Type B Aortic Dissection |
Presenter(s):Donald D. Lee, MD | |
View Slides in PDF | |
2:06 PM - 2:18 PM | Extensive Aorto-Iliac Occlusive Disease: A Modified CERAB Technique |
Presenter(s):Andrew Holden, MBChB | |
View Slides in PDF | |
2:18 PM - 2:30 PM | Hydrodynamic Boost: A Novel Re-Entry Technique In Distal BTK Vessel: When And How To Do It |
Presenter(s):Roberto Ferraresi, MD | |
View Slides in PDF | |
2:30 PM - 2:42 PM | CLI Patient Following 2 Failed Bypass Surgery Procedures Who Was Told The Next Step Would Be Amputation |
Presenter(s):Thomas Zeller, MD | |
View Slides in PDF | |
2:42 PM - 2:54 PM | Endovascular Techniques To Restore The Femoral Artery After Failed Bypass |
Presenter(s):Andrej Schmidt, MD | |
View Slides in PDF | |
2:54 PM - 3:02 PM | General Discussion |
3:02 PM - 3:17 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 44 | |
SESSION 45 SCHEDULE | |
Wednesday
SESSION 45:
INNOVATIVE TECHNIQUES FOR CHALLENGING PERIPHERAL LESIONS
|
|
x | |
3:17 PM - 3:25 PM | Latest Techniques For Aortoiliac Reconstruction Of TASC C And D Lesions: Are Covered Stents The Solution |
Presenter(s):Koen Deloose, MD | |
View Slides in PDF | |
3:25 PM - 3:37 PM | Recorded Case: Chimney Reconstruction Of A Complete Aortoiliac Occlusion (Leriche Syndrome) |
Presenter(s):Peter C.J. Goverde, MD / Andrej Schmidt, MD | |
View Slides in PDF | |
3:37 PM - 3:45 PM | Patient Specific Approaches For Femoropopliteal Lesions: Stents, Atherectomy And Drug-Eluting Devices |
Presenter(s):D. Christopher Metzger, MD | |
View Slides in PDF | |
3:45 PM - 3:57 PM | Recorded Case: Recanalization Of A Severely Calcified SFA Occlusion With Interwoven Nitinol Stents |
Presenter(s):Andrej Schmidt, MD / M. Ulrich, MD | |
3:57 PM - 4:05 PM | The Angiosome Concept For BTK Interventions: How to Translate It Into Clinical Practice |
Presenter(s):Giancarlo Biamino, MD, PhD | |
View Slides in PDF | |
4:05 PM - 4:17 PM | Recorded Case: Recanalization Of A Tibioperoneal Trunc Occlusion With DES Via Retrograde Peroneal Access |
Presenter(s):Andrej Schmidt, MD / C. Piorkowski, MD | |
4:17 PM - 4:25 PM | Current And Future Concepts To Improve Outcome Of BTK-Interventions In CLI |
Presenter(s):Ramon L. Varcoe, MD | |
View Slides in PDF | |
4:25 PM - 4:37 PM | Panel Discussion |
END OF SESSION 45 | |
SESSION 46 SCHEDULE | |
Wednesday
SESSION 46:
MORE TOPICS RELATED TO AAAs, THE AORTA AND EVAR
Moderators:James May, MD, MS, FRACS, FACS / Enrico Ascher, MD
|
|
x | |
4:37 PM - 4:42 PM | How To Manage EVAR With Small Distal Aortas: When Are Bifurcated Grafts OK And When Is An Aorto-Uni-Iliac Device Needed |
Presenter(s):David J. Minion, MD | |
View Slides in PDF | |
4:43 PM - 4:48 PM | Screening For AAAs In Women: When Should They Be Screened And When Should They Not Be |
Presenter(s):Andrew N. Nicolaides, MS, FRCS / Mohsen Chabok, MD, MSc | |
View Slides in PDF | |
4:49 PM - 4:54 PM | Is EVAR Good Treatment For Young (<60) AAA Patients: When Is Open Repair The Best Option |
Presenter(s):Thomas L. Forbes, MD | |
View Slides in PDF | |
4:55 PM - 5:00 PM | DEBATE: Off-Label Use Of EVAR Devices May Have Satisfactory Early Outcomes, But Long-Term Outcomes Are Guarded |
Presenter(s):Ali F. AbuRahma, MD | |
View Slides in PDF | |
5:01 PM - 5:06 PM | DEBATE: Not So: Off-Label Use Of EVAR Devices Is Sometimes Justified And Does Not Yield Higher Long-Term Failure Rates If Certain Requirements Are Fulfilled |
Presenter(s):B. Patrice Mwipatayi, FRACS | |
View Slides in PDF | |
5:07 PM - 5:12 PM | What Has Changed Since Our Oft Quoted 2011 Circulation Article: I Now Believe Some Off-Label Use Of EVAR Devices Is Justified And Safe |
Presenter(s):Andres Schanzer, MD | |
View Slides in PDF | |
5:13 PM - 5:19 PM | Panel Discussion |
Moderator(s): Thomas L. Forbes, MD / Ali F. AbuRahma, MD | |
5:19 PM - 5:24 PM | Has EVAR Led To A Decrease In AAA Rupture Over The Last 2 Decades Or Has It Just Led To More Unnecessary AAA Repairs |
Presenter(s):James May, MD, MS, FRACS, FACS | |
View Slides in PDF | |
5:25 PM - 5:30 PM | The Iliac Seal Zone In EVAR: Its Dynamics And Clinical Consequences |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
View Slides in PDF | |
5:31 PM - 5:36 PM | Diminished Sexual Function In AAA Patients Occurs After EVAR As Well As Open Repair |
Presenter(s):Jan S. Brunkwall, MD, PhD | |
View Slides in PDF | |
5:37 PM - 5:42 PM | Are Newer EVAR Devices Better Than The Previous Ones: Do They Produce Better Results Or Are They Just Easier To Use |
Presenter(s):Marc R.H.M. van Sambeek, MD, PhD | |
View Slides in PDF | |
5:43 PM - 5:48 PM | Patient Reported Quality Of Life (QOL) Measures After Open And Endo AAA Repair: Which Is Better |
Presenter(s):Robert J. Hinchliffe, MD | |
View Slides in PDF | |
5:49 PM - 5:55 PM | Panel Discussion End of Program F |
END OF SESSION 46 |